Syndecan-4 modulates basic fibroblast growth factor 2 signaling in vivo

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 6 53-6, 2003, Pages

  Zhang, Yufeng ^a   Li, Jianyi ^b   Partovian, Chohreh ^a   Sellke, Frank W ^b   Simons, Michael ^a,c  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Heparan sulfate; Nitric oxide; Sodium nitroprusside; Vascular endothelial growth factor

Indexed keywords

CALCIMYCIN; COMPLEMENTARY DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR 2; HEPARAN SULFATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; SYNDECAN; SYNDECAN 4; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; ENDOTHELIUM CELL; HEART; IN VIVO STUDY; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSGENIC MOUSE; VASODILATATION; WILD TYPE;

EID: 0038782000     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00942.2001     Document Type: Article

References (29)

1. Cuevas P, Carceller F, Ortega S, Zazo M, Nieto I, and Gimenez-Gallego G. Hypotensive activity of fibroblast growth factor. Science 254: 1208-1210, 1991.
2. Cuevas P, Garcia-Calvo M, Carceller F, Reimers D, Zazo M, Cuevas B, Munoz-Willery I, Martinez-Coso V, Lamas S, and Gimenez-Gallego G. Correction of hypertension by normalization of endothelial levels of fibroblast growth factor and nitric oxide synthase in spontaneously hypertensive rats. Proc Natl Acad Sci USA 93: 11996-12001, 1996.
3. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, and Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601-605, 1999.
4. Fitzgerald ML, Wang Z, Park PW, Murphy G, and Bernfield M. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J Cell Biol 148: 811-824, 2000.
5. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, and Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399: 597-601, 1999.
6. Guillot PV, Guan J, Liu L, Kuivenhoven JA, Rosenberg RD, Sessa WC, and Aird WC. A vascular bed-specific pathway. J Clin Invest 103: 799-805, 1999.
7. Horowitz A, Murakami M, Gao Y, and Simons M. Phosphatidylinositol-4,5-bisphosphate mediates the interaction of syndecan-4 with protein kinase C. Biochemistry 38: 15871-15877, 1999.
8. Horowitz A and Simons M. Phosphorylation of the cytoplasmic tail of syndecan-4 regulates activation of protein kinase Cα. J Biol Chem 273: 25548-25551, 1998.
9. Horowitz A and Simons M. Regulation of syndecan-4 phosphorylation in vivo. J Biol Chem 273: 10914-10918, 1998.
10. Kent KC, Mii S, Harrington EO, Chang JD, Mallette S, and Ware JA. Requirement for protein kinase C activation in basic fibroblast growth factor-induced human endothelial cell proliferation. Circ Res 77: 231-238, 1995.
11. Klint P and Claesson-Welsh L. Signal transduction by fibroblast growth factor receptors. Front Biosci 4: D165-D177, 1999.
12. Kostyk SK, Kourembanas S, Wheeler EL, Medeiros D, McQuillan LP, D'Amore PA, and Braunhut SJ. Basic fibroblast growth factor increases nitric oxide synthase production in bovine endothelial cells. Am J Physiol Heart Circ Physiol 269: H1583-H1589, 1995.
13. Li J, Post M, Volk R, Gao Y, Li M, Metais C, Sato K, Tsai J, Aird W, Rosenberg RD, Hampton TG, Sellke F, Carmeliet P, and Simons M. PR39, a peptide regulator of angiogenesis. Nat Med 6: 49-55, 2000.
14. Mali M, Elenius K, Miettinen HM, and Jalkanen M. Inhibition of basic fibroblast growth factor-induced growth promotion by overexpression of syndecan-1. J Biol Chem 268: 24215-24222, 1993.
15. Michell BJ, Griffiths JE, Mitchelhill KI, Rodriguez-Crespo I, Tiganis T, Bozinovski S, de Montellano PR, Kemp BE, and Pearson RB. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr Biol 9: 845-848, 1999.
16. Nugent MA and Iozzo RV. Fibroblast growth factor-2. Int J Biochem Cell Biol 32: 115-120, 2000.
17. Oh ES, Woods A, Lim ST, Theibert AW, and Couchman JR. Syndecan-4 proteoglycan cytoplasmic domain and phosphatidylinositol 4,5-bisphosphate coordinately regulate protein kinase C activity. J Biol Chem 273: 10624-10629, 1998.
18. Rapraeger AC, Guimond S, Krufka A, and Olwin BB. Regulation by heparan sulfate in fibroblast growth factor signaling. Methods Enzymol 245: 219-240, 1994.
19. Rosenberg RD, Shworak NW, Liu J, Schwartz JJ, and Zhang L. Heparan sulfate proteoglycans of the cardiovascular system. J Clin Invest 99: 2062-2070, 1997.
20. Sellke FW, Quillen JE, Brooks LA, and Harrison DG. Endothelial modulation of the coronary vasculature in vessels perfused via mature collaterals. Circulation 81: 1938-1947, 1990.
21. Sellke FW, Wang SY, Friedman M, Harada K, Edelman ER, Grossman W, and Simons M. Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation. Am J Physiol Heart Circ Physiol 267: H1303-H1311, 1994.
22. Sellke FW, Wang SY, Stamler A, Lopez JJ, Li J, Li J, and Simons M. Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium. Am J Physiol Heart Circ Physiol 271: H713-H720, 1996.
23. Slavin J. Fibroblast growth factors: at the heart of angiogenesis. Cell Biol Int 19: 431-444, 1995.
24. Subramanian SV, Fitzgerald ML, and Bernfield M. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. J Biol Chem 272: 14713-14720, 1997.
25. Szebenyi G and Fallon JF. Fibroblast growth factors as multifunctional signaling factors. Int Rev Cytol 185: 45-106, 1999.
26. Tsukahara H, Gordienko DV, and Goligorsky MS. Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells. Biochem Biophys Res Commun 193: 722-729, 1993.
27. Tumova S, Woods A, and Couchman JR. Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions. Int J Biochem Cell Biol 32: 269-288, 2000.
28. Volk R, Schwartz JJ, Li J, Rosenberg RD, and Simons M. The role of syndecan cytoplasmic domain in basic fibroblast growth factor-dependent signal transduction. J Biol Chem 274: 24417-24424, 1999.
29. Yayon A, Klagsbrun M, Esko JD, Leder P, and Ornitz DM. Cell surface, heparan-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64: 841-848, 1991.